Cargando…
Lipoperoxide Nanoemulsion as Adjuvant in Cisplatin Cancer Therapy: In Vitro Study on Human Colon Adenocarcinoma DLD-1 Cells
Cisplatin is a first-choice chemotherapeutic agent used to treat solid tumors even though the onset of multi-drug resistance and the time–dose side-effects impair its mono-therapeutic application. Therefore, new drug-delivery approaches, based on nanomedicine strategies, are needed to enhance its th...
Autores principales: | Vernazza, Stefania, Dellacasa, Elena, Tirendi, Sara, Pastorino, Laura, Bassi, Anna Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224288/ https://www.ncbi.nlm.nih.gov/pubmed/34064174 http://dx.doi.org/10.3390/nano11061365 |
Ejemplares similares
-
Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention
por: Vernazza, Stefania, et al.
Publicado: (2021) -
An Innovative In Vitro Open-Angle Glaucoma Model (IVOM) Shows Changes Induced by Increased Ocular Pressure and Oxidative Stress
por: Vernazza, Stefania, et al.
Publicado: (2021) -
Citicoline Eye Drops Protect Trabecular Meshwork Cells from Oxidative Stress Injury in a 3D In Vitro Glaucoma Model
por: Vernazza, Stefania, et al.
Publicado: (2022) -
Neuroinflammation in Primary Open-Angle Glaucoma
por: Vernazza, Stefania, et al.
Publicado: (2020) -
Colorectal cancer and therapy response: a focus on the main mechanisms involved
por: Tirendi, Sara, et al.
Publicado: (2023)